Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN INTERNATIONAL, MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY OF THE SAFETY OF MARAVIROC USED WITH OPTIMIZED BACKGROUND THERAPY IN TREATMENT-EXPERIENCED HIV-1 INFECTED PATIENTS

NCT00665561 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT00665561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00665561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN INTERNATIONAL, MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY OF THE SAFETY OF MARAVIROC USED WITH OPTIMIZED BACKGROUND THERAPY IN TREATMENT-EXPERIENCED HIV-1 INFECTED PATIENTS
Lead sponsor
ViiV Healthcare
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
February 14, 2019
Enrollment
2,500 (actual)
Sites
269

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus